Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...
The American Heart Association and the American College of Cardiology released unified national guidelines for diagnosing and ...
Home remedies for varicose veins, like the application of oil, don’t work, in fact, they delay real treatment and make the ...
The PHA Group has been appointed by the UK Vein Clinic to support the brand’s press office as part of a 12-month campaign, ...
Significantly lower risk for clinically relevant bleeding seen with apixaban than rivaroxaban during three-month trial period.
Courts may deny motions for judgment notwithstanding the verdict when a jury reaches a reasonable decision based on evidence of a patient's failure to follow a prescribed treatment plan.
A trial directly comparing two commonly used blood-thinning drugs found that one carries a lower risk of dangerous bleeding ...
Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the ...
In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.
A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same class of medicines - found that Eliquis carries a clearly lower risk of dangerous bleeding in ...
A new treatment option for menopausal hot flushes and night sweats can be used in the NHS when hormone replacement therapy (HRT) is not suitable. Fezolinetant (also called Veoza and made by Astellas ...
Every year, nearly 900,000 Americans are affected by venous thromboembolism (VTE), a condition in which blood clots form in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results